IC50 values are vital because they provide a quantitative measure to compare the effectiveness of different anticancer drugs. A lower IC50 value indicates higher potency, meaning less of the drug is needed to achieve a 50% reduction in the growth of cancer cells. This information is critical for dose optimization and minimizing side effects in patients.
